Princess Margaret Cancer Centre
SITE-ONC-002-007
ActiveHealthy · 28
Enrolled
13
Screen fail %
29.1%
Open queries
6
Risk score
31
Months active
25
Study assignment
- Sponsor
- Acme Therapeutics
- Study code
- ONC-002
- Therapeutic area
- Oncology
- Indication
- Relapsed/refractory multiple myeloma
Staffing
- Principal investigator
- Dr. Hannah Kowalski
- Site coordinator
- Toront Site Coordinator
- Monitor (CRA)
- CRA — Canada region
Recent activity
| Date | Kind | Summary | Actor |
|---|---|---|---|
| 2026-10-25 | Enrollment | New subject enrolled (Subject 0042) | Dr. Hannah Kowalski |
| 2026-10-22 | Monitoring visit | CRA monitoring visit completed; 12 SDV checks closed | CRA team |
| 2026-10-18 | Query resolved | Two open queries resolved by site coordinator | Site coordinator |
| 2026-10-13 | Signature | Protocol amendment v3 signed by PI | Dr. Hannah Kowalski |
| 2026-10-06 | Query opened | Data management opened query on AE form (Subject 0031) | Data management |
Deviation history
| Date | Severity | Title | CAPA | Status |
|---|---|---|---|---|
| 2026-09-27 | minor | Informed consent re-consent window exceeded | Site retrained on v3 protocol; tracker added. | open |
| 2026-08-28 | major | Visit window exceeded by >7 days for two subjects | CRA flagged subjects; both within protocol-allowed window after review. | under-review |